EGFR and lung carcinoma: EGFR-TKI resistance developed in EGFR-mutated lung cancer cells by Col I absorption via macropinocytosis, while macropinocytosis inhibition reduced Col I absorption in PC-9 cells and restored their EGFR-TKI sensitivity (Yamazaki et al., 2020).